{"id":"W2735576184","doi":"10.1016/s2352-3018(17)30095-4","title":"Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study","year":2017,"lang":"en","type":"article","venue":"The Lancet HIV","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network","funders":"ViiV Healthcare","keywords":"Dolutegravir; Emtricitabine; Medicine; Abacavir; Atazanavir; Ritonavir; Lamivudine; Raltegravir; Regimen; Population; Viral load; Internal medicine; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001949713,0.001647484,0.003311617,0.0006671212,0.000363154,0.001183744,0.001485258,0.001966588,0.009345436],"category_scores_gemma":[0.002409812,0.001126266,0.002487307,0.0004885454,0.001192611,0.001731801,0.0004116787,0.003506731,0.001610969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009517355,"about_ca_system_score_gemma":0.0007338581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001646179,"about_ca_topic_score_gemma":0.003389613,"domain_scores_codex":[0.9990317,0.0005661243,0.00005254905,0.0001469186,0.0000619878,0.0001408019],"domain_scores_gemma":[0.9987642,0.0005120096,0.0002381511,0.0001267473,0.0000518579,0.0003070439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9749374,0.004751673,0.0003264561,0.0003353583,0.0007877859,0.00002776266,0.00006197781,0.0003182263,0.002673313,0.00005832697,0.0003852103,0.01533654],"study_design_scores_gemma":[0.9353989,0.06101562,0.001844336,0.0000294729,0.0004768213,0.00003334475,0.0000340583,0.0003485291,0.0003171366,0.0001525201,0.0003304352,0.0000187878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898053,0.004503113,0.0005644176,0.000562063,0.0003919238,0.00116692,0.001046105,0.000142846,0.001817264],"genre_scores_gemma":[0.990003,0.002312717,0.001277884,0.0006113357,0.0003178337,0.001220284,0.0006601101,0.00004803131,0.00354891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009345436,"threshold_uncertainty_score":0.03126359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05353258789769456,"score_gpt":0.3366963371139196,"score_spread":0.283163749216225,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}